Managing GIST resistance to standard TKI therapy

Date 09 September 2017
Event ESMO 2017 Congress
Session State of the science of targeted treatment in sarcoma
Topics Cytotoxic agents
GIST
Personalised/Precision medicine
Sarcoma
Basic Principles in the Management and Treatment (of cancer)
Therapy
Biological therapy
Presenter Heikki Joensuu
Authors H. Joensuu
  • -, Helsinki University Central Hospital, 00029 - Helsinki/FI